Kadri et al. determined the effect of vitamin A and D combined supplements on interleukin-1β (IL-1β) and clinical outcome in a randomized clinical trial conducted on 120 ischemic stroke patients in four groups (vitamin A or D only, combined vitamin A and D, and placebo for 12 weeks). The gene discussed is IL1B; the disease is ischemic stroke.